David B. Solit

Also affiliated with Cornell University, Kettering University, New York Oncology Hematology, Molecular Oncology (United States)

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

13.5Author DataRank

Indexed papers

12in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 12 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0467

Top 4%

5.0DataRank

Top 4%401 citations

Moriah H. Nissan, Hongxin Zhang, Ritika Kundra, Subhiksha Nandakumar, Calvin Lu +21 more

Papers

Driven by 110 papers — median percentile 0. Top paper: “First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial”.

First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial

The Lancet Oncology(2020)10.1016/s1470-2045(20)30169-8

N/A

5.1DataRank · unranked

360 citations

Steven B. Maron, Walid K. Chatila, Brittanie M Millang, Shweta S. Chavan, Carly Alterman +20 more

Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0467

Top 4%

5.0DataRank

Top 4%401 citations

Moriah H. Nissan, Hongxin Zhang, Ritika Kundra, Subhiksha Nandakumar, Calvin Lu +21 more

A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab124

Top 4%

5.0DataRank

Top 4%199 citations

Walid K. Chatila, Rona Yaeger, Henry Walch, Gustavo dos Santos Fernandes, Asha Krishnan +42 more

Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy

Cancer Cell(2021)10.1016/j.ccell.2021.07.023

N/A

3.9DataRank · unranked

135 citations

Sixue Liu, Zhentao Yang, Alain P. Algazi, Shirley H. Lomeli, Yan Wang +16 more

Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer

Breast Cancer Research(2020)10.1186/s13058-020-01354-y

N/A

3.0DataRank · unranked

148 citations

Cristina Saura, Romualdo Barroso‐Sousa, Hao Guo, Eva Ciruelos, Begoña Bermejo +18 more

Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1283

Top 12%

1.8DataRank

Top 12%68 citations

Michal Sarfaty, Min Yuen Teo, Neha Ratna, Cihan Düzgöl, Samuel A. Funt +18 more

Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma

British Journal of Cancer(2021)10.1038/s41416-020-01244-2

N/A

1.6DataRank · unranked

40 citations

Hikmat Al‐Ahmadie, Kenneth Seier, Christopher Tully, Ashley Marie Regazzi, Eugene J. Pietzak +15 more

First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial

The Lancet Oncology(2023)10.1016/s1470-2045(23)00358-3

N/A

1.5DataRank · unranked

45 citations

Ryan H. Moy, Darren Cowzer, Ronak Shah, Joanne F. Chou, Smita S. Joshi +25 more

Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial

Annals of Oncology(2023)10.1016/j.annonc.2023.08.003

N/A

1.4DataRank · unranked

61 citations

L.D. Eli, Hans Wildiers, Sara A. Hurvitz, Ángel Guerrero‐Zotano, Nisha Unni +37 more

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Nature Medicine(2017)10.1038/nm.4333

N/A

1.2DataRank · unranked

3490 citations

Ryma Benayed, Ronak H Shah, Aijazuddin Syed, Sumit Middha, Hyunjae R. Kim +116 more

AKT mutant allele-specific activation dictates pharmacologic sensitivities

Nature Communications(2022)10.1038/s41467-022-29638-1

N/A

1.2DataRank · unranked

36 citations

Tambudzai Shamu, Alexander N. Gorelick, Matthew T. Chang, Debyani Chakravarty, Elena I. Gavrila +14 more

Cancer therapy shapes the fitness landscape of clonal hematopoiesis

Nature Genetics(2020)10.1038/s41588-020-00710-0

N/A

0.986DataRank · unranked

717 citations

Ryan Ptashkin, Teng Gao, Lior Z. Braunstein, Sean M. Devlin, Daniel J. Kelly +59 more

Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy

Clinical Genitourinary Cancer(2022)10.1016/j.clgc.2022.05.005

N/A

0.937DataRank · unranked

33 citations

Brendan J. Guercio, Arshi Arora, Xueli Hao, Ashley Marie Regazzi, Timothy F. Donahue +25 more

Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4707

Top 22%

0.924DataRank

Top 22%38 citations

Samuel C. Nussenzweig, Henry Walch, Meier Hsu, Kay See Tan, Francisco Sánchez-Vega +16 more

Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion

Nature Genetics(2011)10.1038/ng.936

N/A

0.838DataRank · unranked

266 citations

Michael S. Lawrence, Lear E. Brace, Alex H. Ramos, Timothy R. Dreszer, Kristian Cibulskis +37 more

Germ Cell Tumor Molecular Heterogeneity Revealed Through Analysis of Primary and Metastasis Pairs

JCO Precision Oncology(2020)10.1200/po.20.00166

Top 25%

0.821DataRank

Top 25%17 citations

Mark T.A. Donoghue, François Audenet, Nathan C. Wong, Eugene J. Pietzak, Craig M. Bielski +25 more

Final Results of a Phase I Trial of WST-11 (TOOKAD Soluble) Vascular-targeted Photodynamic Therapy for Upper Tract Urothelial Carcinoma

The Journal of Urology(2023)10.1097/ju.0000000000003202

N/A

0.740DataRank · unranked

26 citations

Daniel D. Sjoberg, Lucas Nogueira, Andrew Tracey, Ricardo Alvim, Peter A. Reisz +16 more

RAS/MAPK Pathway Driver Alterations Are Significantly Associated With Oncogenic KIT Mutations in Germ-cell Tumors

Urology(2020)10.1016/j.urology.2020.07.027

N/A

0.591DataRank · unranked

13 citations

Soo‐Ryum Yang, Donna C. Ferguson, Ying Liu, Rohit Sharma, Jamal Benhamida +11 more

Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study

JCO Precision Oncology(2021)10.1200/po.20.00184

N/A

0.365DataRank · unranked

5 citations

Jonathan Reichel, Jiabin Tang, Juber Patel, Fanli Meng, Duygu Selcuklu +15 more

Circulating Tumor DNA and Response to Cisplatin-based Chemotherapy in Patients with Metastatic Urothelial Carcinoma Enrolled in CALGB 90601 (Alliance)

European Urology Open Science(2025)10.1016/j.euros.2025.03.009

N/A

0.208DataRank · unranked

3 citations

Karissa Whiting, Ronak Shah, Karla V. Ballman, Susan Halabi, Ashley Marie Regazzi +10 more

Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma

Hepatology(2021)10.1002/hep.31829

N/A

0DataRank · unranked

166 citations

Esther Drill, Linda M. Pak, Bastien Nguyen, Carlie Sigel, Alexandre Doussot +27 more

TNFR2/14-3-3ε signaling complex instructs macrophage plasticity in inflammation and autoimmunity

Journal of Clinical Investigation(2021)10.1172/jci144016

N/A

0DataRank · unranked

89 citations

Wenhuo Hu, Young‐Su Yi, Aubryanna Hettinghouse, Guodong Sun, Yufei Bi +10 more

HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway

Nature Communications(2021)10.1038/s41467-021-27093-y

N/A

0DataRank · unranked

88 citations

Emanuela Ferraro, Anton Safonov, Cristina Bernadó Morales, Enrique J. Arenas, Qing Li +10 more

Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary Melanomas

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4189

N/A

0DataRank · unranked

54 citations

Walid K. Chatila, Arshi Arora, Francisco Sánchez-Vega, Havish S. Kantheti, Jorge A. Rojas Zamalloa +18 more

Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0205

N/A

0DataRank · unranked

53 citations

Kyle R. Roell, Markia A. Smith, Xuezheng Sun, Erin L. Kirk, Katherine A. Hoadley +15 more

Molecular and phenotypic profiling of colorectal cancer patients in West Africa reveals biological insights

Nature Communications(2021)10.1038/s41467-021-27106-w

N/A

0DataRank · unranked

44 citations

Gregory Knapp, Avinash Sharma, Walid K. Chatila, Olukayode Arowolo, Olalekan Olasehinde +35 more

Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients

Genome Medicine(2021)10.1186/s13073-021-00898-8

N/A

0DataRank · unranked

58 citations

Michael L. Cheng, Maha Shady, Julie L. Yang, Dennis Stephens, Helen Won +32 more

Overall survival with circulating tumor DNA-guided therapy in advanced non-small cell lung cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.9009

N/A

0DataRank · unranked

19 citations

Emily S. Lebow, Yonina R. Murciano‐Goroff, Gowtham Jayakumaran, Ronglai Shen, A. Rose Brannon +15 more

Large cell neuroendocrine carcinoma of the urothelial tract (LNEC): The MSKCC experience.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4526

N/A

0DataRank · unranked

5 citations

Jatin Gandhi, Min Yuen Teo, Michael Lattanzi, Samuel A. Funt, David H. Aggen +14 more

Genomic characterization of bladder cancer with variant histology.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.470

N/A

0DataRank · unranked

2 citations

Timothy N. Clinton, Wenhuo Hu, Nima Almassi, Peter A. Reisz, Hong Truong +12 more

Early predictors of benefit to dual anti-PD1/HER2 inhibition: Biomarker analysis from phase 2 trial of pembrolizumab/trastuzumab in HER2-positive metastatic esophagogastric (mEG) cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4058

N/A

0DataRank · unranked

2 citations

Walid K. Chatila, Henry Walch, Ryan Ptashkin, Shalom Sabwa, Lilan Ling +13 more

Detection of FGFR3 alt in plasma cfDNA in metastatic UC patients receiving Erda therapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e16519

N/A

0DataRank · unranked

0 citations

Min Yuen Teo, Samuel A. Funt, Chung‐Han Lee, David H. Aggen, Neha Ratna +11 more

Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

Cell(2022)10.1016/j.cell.2022.01.003

N/A

0DataRank · unranked

652 citations

Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar +70 more

Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets

Nature Communications(2022)10.1038/s41467-022-30453-x

N/A

0DataRank · unranked

215 citations

Francisco Sánchez-Vega, Shaleigh Smith, Cristina R. Antonescu, Evan Rosenbaum, Hongyu Shi +42 more

Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

Nature Medicine(2022)10.1038/s41591-022-02047-z

N/A

0DataRank · unranked

195 citations

Emily S. Lebow, Randy Yeh, Jeeban Paul Das, Azadeh Namakydoust, Paul K. Paik +67 more

Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer

Cancer Discovery(2022)10.1158/2159-8290.cd-22-0405

N/A

0DataRank · unranked

140 citations

Riccardo Mezzadra, Jenna Sinopoli, Yu Bian, Michelangelo Marasco, Esther Kaplun +29 more

Anatomic position determines oncogenic specificity in melanoma

Nature(2022)10.1038/s41586-022-04584-6

N/A

0DataRank · unranked

99 citations

Miranda V. Hunter, Nelly M. Cruz, Arianna Baggiolini, Mohita Tagore, Yilun Ma +35 more

Genomic heterogeneity as a barrier to precision oncology in urothelial cancer

Cell Reports(2022)10.1016/j.celrep.2022.111859

N/A

0DataRank · unranked

73 citations

Ziyu Chen, Hannah Wise, Andrew T. Lenis, Shweta S. Chavan, Mark T.A. Donoghue +20 more

Disparities in cancer genetics care by race/ethnicity among pan‐cancer patients with pathogenic germline variants

Cancer(2022)10.1002/cncr.34434

N/A

0DataRank · unranked

44 citations

Anna Maio, Yelena Kemel, Erin Salo‐Mullen, Margaret Sheehan, Prince Ray Tejada +22 more

A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma

Cancer Discovery(2022)10.1158/2159-8290.cd-21-0925

N/A

0DataRank · unranked

33 citations

Lynda Vuong, Josef Leibold, Nicholas H. Chakiryan, Michael Curry, Fengshen Kuo +31 more

Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer

Cancer Epidemiology Biomarkers & Prevention(2022)10.1158/1055-9965.epi-21-1287

N/A

0DataRank · unranked

32 citations

Chaitanya Bandlamudi, Matthew D. Hellmann, Yelena Kemel, Esther Drill, Hira Rizvi +32 more

Analytical Validation and Performance Characteristics of Molecular Serum Biomarkers, miR-371a-3p and miR-372-3p, for Male Germ Cell Tumors, in a Clinical Laboratory Setting

Journal of Molecular Diagnostics(2022)10.1016/j.jmoldx.2022.04.007

N/A

0DataRank · unranked

19 citations

Darren R. Feldman, Alisa Valentino, Rachel So, Maria Bromberg, Shah Alam Khan +6 more

The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-4016

N/A

0DataRank · unranked

15 citations

Samuel C. Nussenzweig, Henry S. Walch, Meier Hsu, Kay See Tan, Sergio De La Torre +13 more

Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1006

N/A

0DataRank · unranked

14 citations

Karissa Whiting, Preethi Srinivasan, Chaitanya Bandlamudi, Aliya Khurram, Vijai Joseph +26 more

BRAF Mutations: The Discovery of Allele- and Lineage-Specific Differences

Cancer Research(2022)10.1158/0008-5472.can-21-3377

N/A

0DataRank · unranked

11 citations

David B. Solit, Aphrothiti J. Hanrahan

Defining and Targeting Esophagogastric Cancer Genomic Subsets With Patient-Derived Xenografts

JCO Precision Oncology(2022)10.1200/po.21.00242

N/A

0DataRank · unranked

9 citations

Henry Walch, Marissa S. Mattar, Walid K. Chatila, Daniela Molena, Vivian E. Strong +10 more

Human epidermal growth factor receptor 2 (HER2) and fibroblast growth factor receptor 3 (FGFR3) mutations to reveal biological pathways in urothelial carcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.567

N/A

0DataRank · unranked

4 citations

Manuel De Jesus Escano, Wesley Yip, Song Jiang, Gopa Iyer, Hikmat Al‐Ahmadie +6 more

Immunogenomic characterization of biliary tract cancers: Biomarker enrichment for benefit to immune checkpoint blockade.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4083

N/A

0DataRank · unranked

3 citations

Fergus Keane, Chaitanya Bandlamudi, Mark T.A. Donoghue, Paulino Tallón de Lara, James J. Harding +15 more

Molecular characterization of acquired resistance to KRAS G12C inhibition in gastrointestinal cancers

Research Square(2022)10.21203/rs.3.rs-1236956/v1

N/A

0DataRank · unranked

2 citations

Rona Yaeger, Riccardo Mezzadra, Jenna Sinopoli, Yu Bian, Michelangelo Marasco +23 more

Upper tract urothelial carcinoma transcriptome profiling and immune microenvironment characterization.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.564

N/A

0DataRank · unranked

2 citations

Kwanghee Kim, Fengshen Kuo, Andrew T. Lenis, Jie‐Fu Chen, Wenhuo Hu +15 more

Defining hereditary upper tract urothelial carcinoma: Implications for genetic testing and clinical management.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.523

N/A

0DataRank · unranked

2 citations

Rania Sheikh, Yelena Kemel, Manuel De Jesus Escano, Aliya Khurram, Peter A. Reisz +15 more

Distinct differences in genomic profile of gastric and gastroesophageal junction adenocarcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.345

Top 100%

0DataRank

Top 100%0 citations

Henry Walch, Walid K. Chatila, Thinh Huy Tran, Elvira L. Vos, Smita Sihag +12 more

Genomic mapping of metastatic organotropism in lung adenocarcinoma

Cancer Cell(2023)10.1016/j.ccell.2023.03.018

N/A

0DataRank · unranked

90 citations

Brooke Mastrogiacomo, James G. Connolly, Kay See Tan, Yuan Liu, Cameron N. Fick +22 more

KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer

Cancer Research(2023)10.1158/0008-5472.can-22-1444

N/A

0DataRank · unranked

52 citations

Vladimir Makarov, Jennifer K. Bolzenius, Angela Halstead, Yvonne Parker, Allen Wang +13 more

Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade

Nature Medicine(2023)10.1038/s41591-023-02544-9

N/A

0DataRank · unranked

38 citations

Michael B. Foote, Benoı̂t Rousseau, Henry Walch, Yelena Kemel, Allison L. Richards +33 more

Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma

Journal of Clinical Investigation(2023)10.1172/jci169823

N/A

0DataRank · unranked

31 citations

Mahdi Golkaram, Joris L. Vos, Bin Xu, Conall Fitzgerald, Mark Lee +17 more

Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1078

N/A

0DataRank · unranked

20 citations

Vignesh Ravichandran, Kathryn Miller, Chad Vanderbilt, Qin Zhou, Alexia Iasonos +17 more

Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma

JCO Precision Oncology(2023)10.1200/po.23.00272

N/A

0DataRank · unranked

18 citations

Jessica White, Joanne F. Chou, Pin‐Jung Chen, Tae‐Hyung Kim, Danny N. Khalil +17 more

Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms

Blood Advances(2023)10.1182/bloodadvances.2022009349

N/A

0DataRank · unranked

10 citations

Oshrat Hershkovitz‐Rokah, Omar Abdel-Wahab, Mariko Yabe, Young Rock Chung, Gilad Itchaki +10 more

Feasibility and tissue concordance of genomic sequencing of urinary cytology in upper tract urothelial carcinoma

Urologic Oncology Seminars and Original Investigations(2023)10.1016/j.urolonc.2023.07.007

N/A

0DataRank · unranked

8 citations

Christopher Gaffney, Sanaz Firouzi, Wesley Yip, Andreas Aulitzky, Eugene J. Pietzak +11 more

Final analysis of multi-histology basket trial expansion of ado-trastuzumab emtansine in patients with HER2 amplified cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.3025

N/A

0DataRank · unranked

9 citations

Vicky Makker, Darren J. Buonocore, Ronglai Shen, Rona Yaeger, Michelle S. Ginsberg +15 more

Data from KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer

(2023)10.1158/0008-5472.c.6514364.v1

N/A

0DataRank · unranked

0 citations

Vladimir Makarov, Jennifer K. Bolzenius, Angela Halstead, Yvonne Parker, Allen Wang +13 more

Data from Novel Mouse Models of Bladder Cancer Identify a Prognostic Signature Associated with Risk of Disease Progression

(2023)10.1158/0008-5472.c.6513832.v1

N/A

0DataRank · unranked

0 citations

Lijie Rong, Tomasz B. Owczarek, Matteo Di Bernardo, Rivka L. Shoulson, Chee Wai Chua +10 more

Data from The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal Melanomas

(2023)10.1158/1078-0432.c.6530294

Top 100%

0DataRank

Top 100%0 citations

Evan J. Lipson, Jody E. Hooper, Amanda Zucker, Jungeui Hong, Craig M. Bielski +17 more

Data from Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer

(2023)10.1158/1078-0432.c.6531197

Top 100%

0DataRank

Top 100%0 citations

Zoe Steinsnyder, Vignesh Ravichandran, Kaitlyn Tkachuk, Yelena Kemel, Chaitanya Bandlamudi +16 more

Data from Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

(2023)10.1158/1078-0432.c.6532764

N/A

0DataRank · unranked

0 citations

Karissa Whiting, Preethi Srinivasan, Chaitanya Bandlamudi, Aliya Khurram, Vijai Joseph +26 more

Data from Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways

(2023)10.1158/1078-0432.c.6529997.v1

Top 100%

0DataRank

Top 100%0 citations

Samuel C. Nussenzweig, Henry Walch, Meier Hsu, Kay See Tan, Francisco Sánchez-Vega +16 more

Data from Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

(2023)10.1158/1078-0432.c.6532764.v1

N/A

0DataRank · unranked

0 citations

Karissa Whiting, Preethi Srinivasan, Chaitanya Bandlamudi, Aliya Khurram, Vijai Joseph +26 more

Data from Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers

(2023)10.1158/1078-0432.c.6532794

N/A

0DataRank · unranked

0 citations

D. Gulhan, Victor Y. Mao, Antuan V. Tran, Madeline Polak, Niya Xiong +14 more

Association of smoking history extracted from electronic health records (EHR) using machine-learning methods and tumor characteristics in patients with lung cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1559

N/A

0DataRank · unranked

0 citations

Andrew Schroeder, Subrata Chatterjee, John Cadley, Christina J. Falcon, Miika Mehine +15 more

An in-progress phase 2 window of opportunity (WOO) trial of targeted therapy with erdafitinib for patients with recurrent FGFR3-altered non–muscle-invasive bladder cancer (NMIBC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps4614

N/A

0DataRank · unranked

0 citations

Christopher Gaffney, Christian Hernández, Patricia Morán, Kara Worth, Melissa McCarter +9 more

BRAF — a tumour-agnostic drug target with lineage-specific dependencies

Nature Reviews Clinical Oncology(2024)10.1038/s41571-023-00852-0

N/A

0DataRank · unranked

125 citations

Ziyu Chen, Neal Rosen, David B. Solit, Aphrothiti J. Hanrahan

Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3403

N/A

0DataRank · unranked

54 citations

Vignesh Ravichandran, Samantha Brown, Syed M. Alam, Andrew Katims, Hong Truong +25 more

Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors

Acta Neuropathologica(2024)10.1007/s00401-024-02736-8

N/A

0DataRank · unranked

28 citations

Vasilisa A. Rudneva, Allison L. Richards, Yanming Zhang, Hyung Jun Woo, Marc A. Cohen +20 more

Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer

Cell(2024)10.1016/j.cell.2024.11.010

N/A

0DataRank · unranked

19 citations

Maria Perry, Samuel I. Gould, Arielle Elkrief, Anton Safonov, Rohit Thummalapalli +23 more

Molecular Heterogeneity and Immune Infiltration Drive Clinical Outcomes in Upper Tract Urothelial Carcinoma

European Urology(2024)10.1016/j.eururo.2024.10.024

N/A

0DataRank · unranked

9 citations

Syed M. Alam, Fengshen Kuo, Ziyu Chen, Wesley Yip, Andrew Katims +34 more

Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications

Modern Pathology(2024)10.1016/j.modpat.2024.100557

N/A

0DataRank · unranked

17 citations

Karissa Whiting, Min-Yuen Teo, Jacob E. Tallman, Gamze Gokturk Ozcan, Merve Başar +21 more

Precision oncology: current and future platforms for treatment selection

Trends in cancer(2024)10.1016/j.trecan.2024.06.009

N/A

0DataRank · unranked

13 citations

Michael F. Berger, David B. Solit, Xinran Tang

pyDarwin machine learning algorithms application and comparison in nonlinear mixed-effect model selection and optimization

Journal of Pharmacokinetics and Pharmacodynamics(2024)10.1007/s10928-024-09932-9

N/A

0DataRank · unranked

7 citations

Mark Sale, Keith Nieforth, James C. Craig, Fenggong Wang, David B. Solit +5 more

Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapy

The Oncologist(2024)10.1093/oncolo/oyae110

N/A

0DataRank · unranked

5 citations

Joanne F. Chou, Henry Walch, Fergus Keane, Danny N. Khalil, Jinru Shia +20 more

Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer

JCO Precision Oncology(2024)10.1200/po.23.00274

N/A

0DataRank · unranked

4 citations

Karissa Whiting, Vignesh Ravichandran, Jacob E. Tallman, Syed M. Alam, Carissa Chu +29 more

Concurrent SOS1 and MEK suppression inhibits signaling and growth of NF1-null melanoma

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101818

N/A

0DataRank · unranked

4 citations

Dinesh Kumar, Tessa Seale, Santiago Garcia Borrego, Esther Kaplun, Ilinca Aricescu +17 more

Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma

European Urology(2025)10.1016/j.eururo.2025.04.008

N/A

0DataRank · unranked

22 citations

Ziyu Chen, Karissa Whiting, Irina Ostrovnaya, Andrew T. Lenis, Timothy N. Clinton +26 more

Leveraging real-world data to advance biomarker discovery and precision oncology

Cancer Cell(2025)10.1016/j.ccell.2025.03.012

N/A

0DataRank · unranked

19 citations

David B. Solit, Jiaqian Luo

Loss of Kmt2c or Kmt2d primes urothelium for tumorigenesis and redistributes KMT2A–menin to bivalent promoters

Nature Genetics(2025)10.1038/s41588-024-02015-y

N/A

0DataRank · unranked

17 citations

Mohini R. Pachai, Dan Li, Cindy J. Lee, Sarah Warda, Makhzuna N. Khudoynazarova +25 more

Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer

Nature Communications(2025)10.1038/s41467-025-62710-0

N/A

0DataRank · unranked

8 citations

Henry M. Delavan, Elizabeth Yip, Corynn Kasap, Jun Zhu, Roshan Lodha +21 more

Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer

Nature Communications(2025)10.1038/s41467-025-67643-2

N/A

0DataRank · unranked

6 citations

Xinran Tang, Jordan Eichholz, Andrew McPherson, Jasmine Thomas, Karan Nagar +23 more

Improving Global Access to Genomic Profiling in Rare Pediatric Cancers

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3910

N/A

0DataRank · unranked

1 citations

Tara J. O’Donohue, Tejus Bale, Anita S. Bowman, Katherine E. Hill, Emily Stockfisch +20 more

Efficacy of Neratinib-Based Therapy in ERBB2-Mutant Lung Adenocarcinomas: Findings From 2 International Phase 2 Studies

Clinical Lung Cancer(2025)10.1016/j.cllc.2025.09.009

N/A

0DataRank · unranked

0 citations

Leena Gandhi, Vignesh Ravichandran, Benjamin Besse, Julien Mazières, Geoffrey I. Shapiro +20 more

Determinants of Sensitivity to HER2-targeted Antibody Drug Conjugates in Urothelial Cancer

Zenodo (CERN European Organization for Nuclear Research)(2025)10.5281/zenodo.17604401

Top 100%

0DataRank

Top 100%0 citations

Xinran Tang, Eichholz, Jordan, David B. Solit, Ziyu Chen

Determinants of Sensitivity to HER2-targeted Antibody Drug Conjugates in Urothelial Cancer

Zenodo (CERN European Organization for Nuclear Research)(2025)10.5281/zenodo.17604400

Top 100%

0DataRank

Top 100%0 citations

Xinran Tang, Eichholz, Jordan, David B. Solit, Ziyu Chen

HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0215

N/A

0DataRank · unranked

293 citations

Flavia Michelini, Sandra Misale, Emiliano Cocco, Laura Baldino, Yanyan Cai +44 more

The FDA approval of pembrolizumab for adult and pediatric patients with tumor mutational burden (TMB) ≥10: a decision centered on empowering patients and their physicians

Annals of Oncology(2020)10.1016/j.annonc.2020.07.002

N/A

0DataRank · unranked

253 citations

David B. Solit, Timothy A. Chan, Razelle Kurzrock, Vivek Subbiah

Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3959

N/A

0DataRank · unranked

119 citations

Shweta S. Chavan, David B. Solit, Rajmohan Murali, Robert A. Soslow, Sarah Chiang +9 more

Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor

Journal of Clinical Investigation(2020)10.1172/jci139682

N/A

0DataRank · unranked

56 citations

Mark T.A. Donoghue, Caleb Ho, Kseniya Petrova‐Drus, Hikmat Al‐Ahmadie, Samuel A. Funt +22 more

Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3322

N/A

0DataRank · unranked

45 citations

Zoe Steinsnyder, Vignesh Ravichandran, Kaitlyn Tkachuk, Yelena Kemel, Chaitanya Bandlamudi +16 more

Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts

Nature Communications(2020)10.1038/s41467-020-15885-7

N/A

0DataRank · unranked

58 citations

Wenhuo Hu, François Audenet, Nima Almassi, Aphrothiti J. Hanrahan, Katie S. Murray +32 more

Fragment Size Analysis May Distinguish Clonal Hematopoiesis from Tumor-Derived Mutations in Cell-Free DNA

Clinical Chemistry(2020)10.1093/clinchem/hvaa026

N/A

0DataRank · unranked

50 citations

Dennis Stephens, Ryan Ptashkin, Ahmet Zehir, Michael F. Berger, David B. Solit +3 more

Protein-altering germline mutations implicate novel genes related to lung cancer development

Nature Communications(2020)10.1038/s41467-020-15905-6

N/A

0DataRank · unranked

49 citations

Semanti Mukherjee, Maria Teresa Landi, Yohan Bossé, Philippe Joubert, Dakai Zhu +95 more

MAPK Pathway Alterations Correlate with Poor Survival and Drive Resistance to Therapy in Patients with Lung Cancers Driven by ROS1 Fusions

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3321

N/A

0DataRank · unranked

48 citations

Adam J. Schoenfeld, Evan Siau, Yue Christine Lu, Huichun Tai, Ken Suzawa +17 more

AKT1 E17K Inhibits Cancer Cell Migration by Abrogating β-Catenin Signaling

Molecular Cancer Research(2020)10.1158/1541-7786.mcr-20-0623

N/A

0DataRank · unranked

21 citations

Amber J. Kiliti, Kai Zhang, Naresh Vasani, Ninghui Mao, Emmet Jordan +14 more

Overcoming Adaptive Resistance to KRAS Inhibitors Through Vertical Pathway Targeting

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-4060

N/A

0DataRank · unranked

40 citations

David B. Solit, Rona Yaeger

Leveraging Systematic Functional Analysis to Benchmark an In Silico Framework Distinguishes Driver from Passenger MEK Mutants in Cancer

Cancer Research(2020)10.1158/0008-5472.can-20-0865

N/A

0DataRank · unranked

31 citations

Brooke E. Sylvester, Matthew T. Chang, Arijh Elzein, Jianjiong Gao, Weiwei Han +24 more

Anatomic position determines oncogenic specificity in melanoma

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.11.14.383083

N/A

0DataRank · unranked

13 citations

Miranda V. Hunter, Nelly M. Cruz, Arianna Baggiolini, Mohita Tagore, Yilun Ma +35 more

Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4559

N/A

0DataRank · unranked

6 citations

Walid K. Chatila, Brittanie M Millang, Shalom Sabwa, Joanne F. Chou, Lilan Ling +15 more

Effects of radiation therapy on clonal hematopoiesis.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.12062

N/A

0DataRank · unranked

1 citations

N. Ari Wijetunga, Minal Patel, Teng Gao, Ryan Ptashkin, Michael R Sullivan +12 more

The current state of preclinical prostate cancer animal models

UNC Libraries(2020)10.17615/kfq3-9222

N/A

0DataRank · unranked

0 citations

J.W. Simons, Terry A. VanDyke, Leland W.K. Chung, Kenneth J. Pienta, Howard R. Soule +12 more

Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion

UNC Libraries(2020)10.17615/wq19-7x17

N/A

0DataRank · unranked

0 citations

Adam J. Bass, Alex H. Ramos, Yujin Hoshida, Andrey Sivachenko, Trevor J. Pugh +27 more

The association between tumor mutational burden and prognosis is dependent on treatment context

Nature Genetics(2021)10.1038/s41588-020-00752-4

N/A

0DataRank · unranked

262 citations

Mark Lee, Douglas R. Hoen, Jingming Wang, Zaineb Nadeem, Neal Patel +22 more

Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS

Nature Communications(2021)10.1038/s41467-021-24109-5

N/A

0DataRank · unranked

183 citations

Gowtham Jayakumaran, Monica Diosdado, Juber Patel, Anna Razumova, Yu Hu +64 more

David B. Solit

Indexed papers

Top data-sharing exemplar

Papers